DVAX
Dynavax Technologies Corp
Price Chart
No historical data available
Latest Quote
$15.50
+0.00 (+0.00%)
Current Price
| Previous Close | $15.50 |
Stock Information
| Shares Outstanding | 113.68M |
| Total Debt | $289.22M |
| Cash Equivalents | $647.81M |
| Revenue | $330.51M |
| Net Income | $-43.40M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $1.82B |
| EPS (TTM) | $-0.37 |
| Exchange | NMS |
Recent Price History
No history data available. Data will be fetched automatically.
About Dynavax Technologies Corp
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccine candidate in Phase 1/2 clinical trial for the prevention of shingles in adults aged 50 years and older, as well as HEPLISAV-B for adults on hemodialysis. The company sells its products to hospitals and clinics, integrated delivery networks, public health clinics and prisons, the Department of Defense, the Department of Veterans Affairs, and retail pharmacies through wholesalers and specialty distributors. It has a collaboration agreement with the U.S. Department of Defense; Coalition for Epidemic Preparedness Innovations; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; and Biological E. Limited. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
đ° Latest News
Sanofi Buyout Ends Dynavax Listing And Shifts Vaccine Upside To Group
Simply Wall St. âĸ 2026-02-11T00:16:39Z
A Look At Dynavax Technologies (DVAX) Valuation As Pipeline Prospects Meet Conflicting Fair Value Estimates
Simply Wall St. âĸ 2026-02-10T23:12:48Z
Is It Time To Reassess Dynavax (DVAX) After The Agreed Sanofi Cash Acquisition Deal
Simply Wall St. âĸ 2026-02-10T21:12:40Z
Dynavax President and COO Sells 114,000 Shares on Sanofi Acquisition News
Motley Fool âĸ 2026-01-30T14:53:52Z
Sanofi Beats on Q4 Earnings, Expects Profitable Growth in 2026
Zacks âĸ 2026-01-29T16:21:00Z
High Growth Tech Stocks To Watch In The US January 2026
Simply Wall St. âĸ 2026-01-22T11:38:18Z
Jim Cramer Highlights Sanofiâs Bid for Dynavax
Insider Monkey âĸ 2026-01-14T15:57:40Z
Is It Time To Reassess Dynavax Technologies (DVAX) After Its Recent Share Price Surge
Simply Wall St. âĸ 2026-01-11T01:09:44Z
Where is Sanofi (SNY) Headed According to Wall Street?
Insider Monkey âĸ 2025-12-30T04:59:56Z
Sanofi Agrees to Buy Dynavax for $2.2 Billion After FDA MS Drug Rejection
GuruFocus.com âĸ 2025-12-29T10:28:54Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $49,445,000 | $50,167,000 | $262,153,000 | $173,572,000 |
| Cost Of Revenue | $49,445,000 | $50,167,000 | $262,153,000 | $173,572,000 |
| Total Revenue | $277,246,000 | $232,284,000 | $722,683,000 | $439,442,000 |
| Operating Revenue | $268,430,000 | $213,295,000 | $713,645,000 | $437,099,000 |
| Expenses | ||||
| Interest Expense | $6,794,000 | $6,757,000 | $6,732,000 | $11,176,000 |
| Total Expenses | $281,368,000 | $257,999,000 | $440,161,000 | $305,956,000 |
| Other Income Expense | $5,307,000 | $-3,888,000 | $10,597,000 | $-44,929,000 |
| Other Non Operating Income Expenses | $5,307,000 | $7,425,000 | $7,796,000 | $8,657,000 |
| Net Non Operating Interest Income Expense | $29,670,000 | $25,236,000 | $1,180,000 | $-11,036,000 |
| Interest Expense Non Operating | $6,794,000 | $6,757,000 | $6,732,000 | $11,176,000 |
| Operating Expense | $231,923,000 | $207,832,000 | $178,008,000 | $132,384,000 |
| General And Administrative Expense | $170,373,000 | $152,946,000 | $131,408,000 | $100,156,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $27,309,000 | $-6,389,000 | $293,156,000 | $76,713,000 |
| Net Interest Income | $29,670,000 | $25,236,000 | $1,180,000 | $-11,036,000 |
| Interest Income | $36,464,000 | $31,993,000 | $7,912,000 | $140,000 |
| Normalized Income | $27,309,000 | $2,548,270 | $290,365,879 | $129,763,140 |
| Net Income From Continuing And Discontinued Operation | $27,309,000 | $-6,389,000 | $293,156,000 | $76,713,000 |
| Total Operating Income As Reported | $-4,122,000 | $-37,028,000 | $283,522,000 | $134,486,000 |
| Average Dilution Earnings | $0 | $0 | $3,526,000 | $3,547,000 |
| Net Income Common Stockholders | $27,309,000 | $-6,389,000 | $292,873,000 | $72,144,000 |
| Net Income | $27,309,000 | $-6,389,000 | $293,156,000 | $76,713,000 |
| Net Income Including Noncontrolling Interests | $27,309,000 | $-6,389,000 | $293,156,000 | $76,713,000 |
| Net Income Continuous Operations | $27,309,000 | $-6,389,000 | $293,156,000 | $76,713,000 |
| Pretax Income | $30,855,000 | $-4,367,000 | $294,299,000 | $77,521,000 |
| Special Income Charges | $0 | $-11,313,000 | $1,000,000 | $-4,232,000 |
| Interest Income Non Operating | $36,464,000 | $31,993,000 | $7,912,000 | $140,000 |
| Operating Income | $-4,122,000 | $-25,715,000 | $282,522,000 | $133,486,000 |
| Gross Profit | $227,801,000 | $182,117,000 | $460,530,000 | $265,870,000 |
| Per Share | ||||
| Diluted EPS | $0.20 | $-0.05 | $1.97 | $0.57 |
| Basic EPS | $0.21 | $-0.05 | $2.32 | $0.62 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $-2,375,730 | $10,879 | $-535,860 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $45,701,000 | $20,979,000 | $304,898,000 | $149,341,000 |
| Total Unusual Items | $0 | $-11,313,000 | $2,801,000 | $-53,586,000 |
| Total Unusual Items Excluding Goodwill | $0 | $-11,313,000 | $2,801,000 | $-53,586,000 |
| Reconciled Depreciation | $8,052,000 | $7,276,000 | $6,668,000 | $7,058,000 |
| EBITDA (Bullshit earnings) | $45,701,000 | $9,666,000 | $307,699,000 | $95,755,000 |
| EBIT | $37,649,000 | $2,390,000 | $301,031,000 | $88,697,000 |
| Diluted Average Shares | $133,344,000 | $128,733,000 | $150,797,000 | $133,006,000 |
| Basic Average Shares | $130,047,000 | $128,733,000 | $126,398,000 | $116,264,000 |
| Diluted NI Availto Com Stockholders | $27,309,000 | $-6,389,000 | $296,399,000 | $75,691,000 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $283,000 | $4,569,000 |
| Tax Provision | $3,546,000 | $2,022,000 | $1,143,000 | $808,000 |
| Gain On Sale Of Ppe | $0 | $1,000,000 | $1,000,000 | $1,000,000 |
| Write Off | $0 | $12,313,000 | $0 | $0 |
| Research And Development | $61,550,000 | $54,886,000 | $46,600,000 | $32,228,000 |
| Selling General And Administration | $170,373,000 | $152,946,000 | $131,408,000 | $100,156,000 |
| Other Gand A | $64,990,000 | $59,940,000 | $55,425,000 | $42,127,000 |
| Salaries And Wages | $105,383,000 | $93,006,000 | $75,983,000 | $58,029,000 |
| Gain On Sale Of Security | - | - | $1,801,000 | $-49,354,000 |
| Other Special Charges | - | - | - | $5,232,000 |
| Restructuring And Mergern Acquisition | - | - | - | $0 |
Fetched: 2026-02-09
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $594,853,000 | $620,005,000 | $579,007,000 | $220,249,000 |
| Total Assets | $986,256,000 | $997,096,000 | $985,850,000 | $1,039,246,000 |
| Total Non Current Assets | $137,315,000 | $137,976,000 | $68,865,000 | $66,726,000 |
| Other Non Current Assets | $74,760,000 | $74,325,000 | $3,518,000 | $3,617,000 |
| Goodwill And Other Intangible Assets | $1,946,000 | $2,067,000 | $2,006,000 | $2,125,000 |
| Current Assets | $848,941,000 | $859,120,000 | $916,985,000 | $972,520,000 |
| Other Current Assets | $18,147,000 | $18,995,000 | $85,629,000 | $73,764,000 |
| Inventory | $70,054,000 | $53,290,000 | $59,446,000 | $61,335,000 |
| Receivables | $46,906,000 | $44,533,000 | $147,515,000 | $131,816,000 |
| Other Receivables | $1,625,000 | $3,926,000 | $2,385,000 | $15,600,000 |
| Accounts Receivable | $45,281,000 | $40,607,000 | $145,130,000 | $116,216,000 |
| Allowance For Doubtful Accounts Receivable | $-12,313,000 | $-12,313,000 | $0 | - |
| Gross Accounts Receivable | $57,594,000 | $52,920,000 | $145,130,000 | - |
| Cash Cash Equivalents And Short Term Investments | $713,834,000 | $742,302,000 | $624,395,000 | $545,950,000 |
| Cash And Cash Equivalents | $95,883,000 | $150,279,000 | $202,004,000 | $436,189,000 |
| Cash Equivalents | $83,726,000 | $139,089,000 | $172,418,000 | $429,194,000 |
| Cash Financial | $12,157,000 | $11,190,000 | $29,586,000 | $6,995,000 |
| Prepaid Assets | - | - | $0 | $159,655,000 |
| Debt | ||||
| Net Debt | $127,971,000 | $72,419,000 | $19,574,000 | - |
| Total Debt | $254,417,000 | $256,914,000 | $258,010,000 | $257,383,000 |
| Long Term Debt And Capital Lease Obligation | $250,242,000 | $252,418,000 | $254,379,000 | $254,806,000 |
| Long Term Debt | $223,854,000 | $222,698,000 | $221,578,000 | $220,490,000 |
| Current Debt And Capital Lease Obligation | $4,175,000 | $4,496,000 | $3,631,000 | $2,577,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $389,457,000 | $375,024,000 | $404,837,000 | $816,872,000 |
| Total Non Current Liabilities Net Minority Interest | $310,823,000 | $312,829,000 | $254,763,000 | $260,470,000 |
| Other Non Current Liabilities | $244,000 | $74,000 | $384,000 | $5,664,000 |
| Current Liabilities | $78,634,000 | $62,195,000 | $150,074,000 | $556,402,000 |
| Other Current Liabilities | $22,000 | $24,000 | - | $18,029,000 |
| Payables And Accrued Expenses | $74,437,000 | $57,675,000 | $146,443,000 | $185,932,000 |
| Payables | $9,061,000 | $5,245,000 | $3,211,000 | $2,600,000 |
| Accounts Payable | $9,061,000 | $5,245,000 | $3,211,000 | $2,600,000 |
| Current Deferred Liabilities | - | - | $0 | $349,864,000 |
| Equity | ||||
| Common Stock Equity | $596,799,000 | $622,072,000 | $581,013,000 | $222,374,000 |
| Total Equity Gross Minority Interest | $596,799,000 | $622,072,000 | $581,013,000 | $222,374,000 |
| Stockholders Equity | $596,799,000 | $622,072,000 | $581,013,000 | $222,374,000 |
| Gains Losses Not Affecting Retained Earnings | $-4,722,000 | $-2,108,000 | $-5,438,000 | $-2,266,000 |
| Other Equity Adjustments | $-4,722,000 | $-2,108,000 | $-5,438,000 | - |
| Retained Earnings | $-903,275,000 | $-930,584,000 | $-924,195,000 | $-1,217,351,000 |
| Other | ||||
| Ordinary Shares Number | $125,450,000 | $129,530,000 | $127,604,000 | $122,945,000 |
| Share Issued | $125,450,000 | $129,530,000 | $127,604,000 | $122,945,000 |
| Tangible Book Value | $594,853,000 | $620,005,000 | $579,007,000 | $220,249,000 |
| Invested Capital | $820,653,000 | $844,770,000 | $802,591,000 | $442,864,000 |
| Working Capital | $770,307,000 | $796,925,000 | $766,911,000 | $416,118,000 |
| Capital Lease Obligations | $30,563,000 | $34,216,000 | $36,432,000 | $36,893,000 |
| Total Capitalization | $820,653,000 | $844,770,000 | $802,591,000 | $442,864,000 |
| Additional Paid In Capital | $1,504,671,000 | $1,554,634,000 | $1,510,518,000 | $1,441,868,000 |
| Capital Stock | $125,000 | $130,000 | $128,000 | $123,000 |
| Common Stock | $125,000 | $130,000 | $128,000 | $123,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Accrued Expenses | $60,337,000 | $60,337,000 | $0 | - |
| Long Term Capital Lease Obligation | $26,388,000 | $29,720,000 | $32,801,000 | $34,316,000 |
| Current Capital Lease Obligation | $4,175,000 | $4,496,000 | $3,631,000 | $2,577,000 |
| Current Accrued Expenses | $65,376,000 | $52,430,000 | $143,232,000 | $183,332,000 |
| Goodwill | $1,946,000 | $2,067,000 | $2,006,000 | $2,125,000 |
| Net PPE | $60,609,000 | $61,584,000 | $63,341,000 | $60,984,000 |
| Accumulated Depreciation | $-34,166,000 | $-31,832,000 | $-27,522,000 | $-25,378,000 |
| Gross PPE | $94,775,000 | $93,416,000 | $90,863,000 | $86,362,000 |
| Leases | $36,535,000 | $37,201,000 | $28,822,000 | $27,634,000 |
| Construction In Progress | $10,122,000 | $5,822,000 | $11,613,000 | $9,941,000 |
| Other Properties | $39,755,000 | $42,866,000 | $43,244,000 | $40,988,000 |
| Machinery Furniture Equipment | $8,363,000 | $7,527,000 | $7,184,000 | $7,799,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $12,846,000 | $7,080,000 | $9,995,000 | $19,950,000 |
| Work In Process | $14,569,000 | $18,954,000 | $23,934,000 | $14,748,000 |
| Raw Materials | $42,639,000 | $27,256,000 | $25,517,000 | $26,637,000 |
| Other Short Term Investments | $617,951,000 | $592,023,000 | $422,391,000 | $109,761,000 |
| Current Deferred Revenue | - | - | $0 | $349,864,000 |
Fetched: 2026-02-09
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $60,160,000 | $96,459,000 | $55,577,000 | $326,051,000 |
| Operating Activities | ||||
| Operating Cash Flow | $66,512,000 | $100,563,000 | $62,716,000 | $335,528,000 |
| Cash Flow From Continuing Operating Activities | $66,512,000 | $100,563,000 | $62,716,000 | $335,528,000 |
| Operating Gains Losses | - | $-1,000,000 | $-2,801,000 | $53,586,000 |
| Investing Activities | ||||
| Capital Expenditure | $-6,352,000 | $-4,104,000 | $-7,139,000 | $-9,477,000 |
| Investing Cash Flow | $-18,035,000 | $-153,928,000 | $-315,995,000 | $14,225,000 |
| Cash Flow From Continuing Investing Activities | $-18,035,000 | $-153,928,000 | $-315,995,000 | $14,225,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-100,000,000 | $0 | $0 | - |
| Financing Cash Flow | $-102,017,000 | $1,386,000 | $19,525,000 | $55,776,000 |
| Cash Flow From Continuing Financing Activities | $-102,017,000 | $1,386,000 | $19,525,000 | $55,776,000 |
| Net Other Financing Charges | $-9,306,000 | $-6,509,000 | - | $-27,240,000 |
| Net Common Stock Issuance | $-100,000,000 | $0 | $0 | $28,156,000 |
| Issuance Of Capital Stock | - | $0 | $0 | $28,156,000 |
| Common Stock Issuance | - | $0 | $0 | $28,156,000 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Interest Paid Supplemental Data | $5,638,000 | $5,638,000 | $5,638,000 | $9,815,000 |
| Income Tax Paid Supplemental Data | $4,585,000 | $2,014,000 | $2,208,000 | $1,312,000 |
| End Cash Position | $96,154,000 | $150,556,000 | $202,211,000 | $436,408,000 |
| Beginning Cash Position | $150,556,000 | $202,211,000 | $436,408,000 | $32,310,000 |
| Effect Of Exchange Rate Changes | $-862,000 | $324,000 | $-443,000 | $-1,431,000 |
| Changes In Cash | $-53,540,000 | $-51,979,000 | $-233,754,000 | $405,529,000 |
| Proceeds From Stock Option Exercised | $7,289,000 | $7,895,000 | $19,525,000 | $25,232,000 |
| Common Stock Payments | $-100,000,000 | $0 | $0 | - |
| Net Investment Purchase And Sale | $-11,683,000 | $-150,824,000 | $-309,856,000 | $22,702,000 |
| Sale Of Investment | $512,380,000 | $486,097,000 | $322,450,000 | $187,630,000 |
| Purchase Of Investment | $-524,063,000 | $-636,921,000 | $-632,306,000 | $-164,928,000 |
| Net Intangibles Purchase And Sale | $0 | $1,000,000 | $1,000,000 | $1,000,000 |
| Sale Of Intangibles | $0 | $1,000,000 | $1,000,000 | $1,000,000 |
| Net PPE Purchase And Sale | $-6,352,000 | $-4,104,000 | $-7,139,000 | $-9,477,000 |
| Purchase Of PPE | $-6,352,000 | $-4,104,000 | $-7,139,000 | $-9,477,000 |
| Change In Working Capital | $-16,037,000 | $61,206,000 | $-298,417,000 | $172,220,000 |
| Change In Other Current Liabilities | $-4,387,000 | $-3,629,000 | $-3,125,000 | $-3,234,000 |
| Change In Other Current Assets | $-1,190,000 | $570,000 | $87,000 | $175,000 |
| Change In Payables And Accrued Expense | $14,932,000 | $21,761,000 | $-45,207,000 | $167,806,000 |
| Change In Accrued Expense | $11,033,000 | $19,809,000 | $-45,898,000 | $168,573,000 |
| Change In Payable | $3,899,000 | $1,952,000 | $691,000 | $-767,000 |
| Change In Account Payable | $3,899,000 | $1,952,000 | $691,000 | $-767,000 |
| Change In Prepaid Assets | $-3,110,000 | $-4,673,000 | $147,790,000 | $-194,790,000 |
| Change In Inventory | $-19,909,000 | $3,909,000 | $-32,399,000 | $-234,000 |
| Change In Receivables | $-2,373,000 | $43,268,000 | $-15,699,000 | $-109,155,000 |
| Other Non Cash Items | $5,970,000 | $1,120,000 | $1,088,000 | $1,608,000 |
| Stock Based Compensation | $52,619,000 | $42,592,000 | $32,915,000 | $21,285,000 |
| Asset Impairment Charge | $3,144,000 | $12,313,000 | $34,288,000 | $2,588,000 |
| Amortization Of Securities | $-14,545,000 | $-16,555,000 | $-4,181,000 | $470,000 |
| Depreciation Amortization Depletion | $8,052,000 | $7,276,000 | $6,668,000 | $7,058,000 |
| Depreciation And Amortization | $8,052,000 | $7,276,000 | $6,668,000 | $7,058,000 |
| Depreciation | $8,052,000 | $7,276,000 | $6,668,000 | $7,058,000 |
| Net Income From Continuing Operations | $27,309,000 | $-6,389,000 | $293,156,000 | $76,713,000 |
| Repayment Of Debt | - | $0 | $0 | $-190,194,000 |
| Issuance Of Debt | - | $0 | $0 | $219,822,000 |
| Net Issuance Payments Of Debt | - | $0 | $0 | $29,628,000 |
| Net Long Term Debt Issuance | - | $0 | $0 | $29,628,000 |
| Long Term Debt Payments | - | $0 | $0 | $-190,194,000 |
| Long Term Debt Issuance | - | $0 | $0 | $219,822,000 |
| Purchase Of Intangibles | - | - | $0 | $0 |
| Change In Other Working Capital | - | - | $-349,864,000 | $311,652,000 |
| Amortization Cash Flow | - | - | $0 | $0 |
| Amortization Of Intangibles | - | - | $0 | $0 |
| Gain Loss On Investment Securities | - | - | $-1,801,000 | $49,354,000 |
| Gain Loss On Sale Of PPE | - | - | $0 | $47,000 |
Fetched: 2026-02-09